ロード中...
DNA damage repair in ovarian cancer: unlocking the heterogeneity
Treatment for advanced ovarian cancer is rarely curative; three quarters of patients with advanced disease relapse and ultimately die with resistant disease. Improving patient outcomes will require the introduction of new treatments and better patient selection. Abrogations in the DNA damage respons...
保存先:
| 出版年: | J Ovarian Res |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6011341/ https://ncbi.nlm.nih.gov/pubmed/29925418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-018-0424-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|